# Oaktree Specialty Lending Corp: overview

OCSL · Nasdaq · CIK 1414932 · [Other](/sectors/other.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/ocsl.md) · [Financials](/companies/ocsl/financials.md) · [Filings](/companies/ocsl/filings.md) · [Insiders](/companies/ocsl/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | [0.09](/filings/0001414932-26-000005.md) | [(0.42)](/filings/0001414932-26-000012.md) | [0.44](/filings/0001414932-26-000017.md) | not reported | [0.06](/filings/0001414932-26-000005.md) | [(0.21)](/filings/0001414932-26-000012.md) | [0.35](/filings/0001414932-26-000017.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-09-30) | FY (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [4.39](/filings/0001414932-23-000018.md) | [0.48](/filings/0001414932-24-000016.md) | [1.63](/filings/0001414932-25-000022.md) | [0.72](/filings/0001414932-25-000022.md) | [0.39](/filings/0001414932-25-000022.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ocsl/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [OAKTREE CAPITAL MANAGEMENT LP](/funds/949509.md) | 2026-06-30 | $94.0m | 7,872,199 |  | Added +6,019,743 |
| [PRIVATE MANAGEMENT GROUP INC](/funds/1142031.md) | 2026-06-30 | $46.2m | 3,869,484 |  | Added +147,990 |
| [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $34.9m | 2,924,437 |  | Added +2,444,777 |
| [BRUNI J V & CO /CO](/funds/1078841.md) | 2026-06-30 | $29.5m | 2,474,804 |  | Reduced −23,070 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $28.7m | 2,401,489 |  | Reduced −160,315 |
| [ARES MANAGEMENT LLC](/funds/1259313.md) | 2026-06-30 | $26.3m | 2,204,305 |  | Added +105,000 |
| [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $26.2m | 2,195,651 |  | Added +492,070 |
| [Generali Asset Management SPA SGR](/funds/2046751.md) | 2026-06-30 | $24.8m | 2,080,867 |  | Reduced −7,114 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $24.8m | 2,080,105 |  | Added +710,360 |
| [Russell Investments Group, Ltd.](/funds/1692234.md) | 2026-06-30 | $12.6m | 1,054,187 |  | Added +333,469 |

## Recent filings

[All 1,138 filings](/companies/ocsl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-16 | 16:05 ET | [8-K](/filings/0001193125-26-393060.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-393060 |
| 2026-09-11 | 16:06 ET | [8-K](/filings/0001193125-26-389266.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-389266 |
| 2026-08-05 | 06:10 ET | [8-K](/filings/0001193125-26-333737.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-333737 |
| 2026-08-05 | 17:55 ET | [10-Q](/filings/0001414932-26-000017.md) | Quarterly report, period 2026-06-30 | 0001414932-26-000017 |
| 2026-05-05 | 06:01 ET | [8-K](/filings/0001193125-26-204937.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-204937 |
| 2026-05-05 | 18:21 ET | [10-Q](/filings/0001414932-26-000012.md) | Quarterly report, period 2026-03-31 | 0001414932-26-000012 |
| 2026-03-04 | 16:05 ET | [8-K](/filings/0001193125-26-091472.md) | 5.07 Shareholder vote results | 0001193125-26-091472 |
| 2026-02-04 | 06:12 ET | [8-K](/filings/0001193125-26-036643.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-036643 |
| 2026-02-04 | 18:50 ET | [10-Q](/filings/0001414932-26-000005.md) | Quarterly report, period 2025-12-31 | 0001414932-26-000005 |
| 2026-01-16 | 15:50 ET | [DEF 14A](/filings/0001193125-26-015232.md) | Proxy statement, period 2026-03-03 | 0001193125-26-015232 |

## Latest annual report

[Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0001414932-25-000022.md), filed Nov 18, 2025.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1414932
- Tickers: OCSL
- Exchange: Nasdaq
- SIC code: not reported
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.